Cedars-Sinai has appointed urologic oncologist, surgeon, and research investigator Hyung Kim, MD, as the inaugural Chair of the newly established Department of Urology.
Hyung Kim, MD
“Dr. Kim is an outstanding clinical and academic leader who will strategically steer our urology enterprise,” said Shlomo Melmed, MB, ChB, Executive Vice President of Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai. “A highly accomplished urologic oncologist, surgeon, and National Institutes of Health [NIH]-funded investigator, he brings a demonstrated commitment to clinical excellence, research innovation, and medical education to the new department.”
Ongoing Leadership
Dr. Kim joined Cedars-Sinai in 2009 and currently is Professor of Surgery and the Homer and Gloria Harvey Family Chair in Urologic Oncology in honor of Stuart Friedman, MD. He has led Cedars-Sinai’s Academic Urology Program for more than 6 years.
Shlomo Melmed, MB, ChB
Jeff Smith, MD, JD, MMM
“During this time, the division has experienced remarkable clinical, research, and academic flourishing,” said Jeff Smith, MD, JD, MMM, Executive Vice President of Hospital Operations and Chief Operating Officer at Cedars-Sinai. Dr. Kim also has played an instrumental role in creating the Urology Residency Program at Cedars-Sinai, which now receives 80% of all urology resident applications in the country.
Dr. Kim is Co–Medical Director of the Urologic Oncology Center. He specializes in treating complex and challenging cancers of the kidneys, prostate, and bladder. He is the author of more than 100 research publications and runs an NIH-funded research laboratory that develops novel cancer therapies. He also is the co–principal investigator of a national phase III clinical trial testing cytoreductive nephrectomy in patients with metastatic kidney cancer.
“Cedars-Sinai has a world-class urology program consisting of a group of highly renowned surgeons and urologic researchers,” Dr. Kim said. “I’m excited about working to further build a collaborative environment, where clinicians and researchers can together address some of the foremost challenges in urology health.”
